The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties

Cellular Immunology

Volumn 270, Issue 2, 2011, Pages 207-216

  Raicevic, Gordana ^a,b   Najar, Mehdi ^a,b   Stamatopoulos, Basile ^a,b   De Bruyn, Cecile ^a,b   Meuleman, Nathalie ^b   Bron, Dominique ^a,b   Toungouz, Michel ^b,c   Lagneaux, Laurence ^a,b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b JULES BORDET INSTITUTE   (Belgium)

^c ERASME HOSPITAL   (Belgium)

Author keywords

Adipose tissue; Bone marrow; Hepatic growth factor (HGF); Inflammation; Mesenchymal stromal cells; Toll like receptors (TLRs); Wharton's jelly

Indexed keywords

TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4;

ARTICLE; CELL THERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EMBRYO; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; MESENCHYME CELL; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; STROMA CELL;

EID: 80051670366     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.05.010     Document Type: Article

References (60)

1. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., Moorman M.A., Simonetti D.W., Craig S., Marshak D.R. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
2. Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 2003, 31:890-896.
3. Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 2003, 57:11-20.
4. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
5. Uccelli A., Moretta L., Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur. J. Immunol. 2006, 36:2566-2573.
6. Corcione A., Benvenuto F., Ferretti E., Giunti D., Cappiello V., Cazzanti F., Risso M., Gualandi F., Mancardi G.L., Pistoia V., Uccelli A. Human mesenchymal stem cells modulate B-cell functions. Blood 2006, 107:367-372.
7. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., Dazzi F. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003, 101:3722-3729.
8. Najar M., Rouas R., Raicevic G., Id B.H., Lewalle P., Meuleman N., Bron D., Toungouz M., Martiat P., Lagneaux L. Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. Cytotherapy 2009, 1-14.
9. Beyth S., Borovsky Z., Mevorach D., Liebergall M., Gazit Z., Aslan H., Galun E., Rachmilewitz J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 2005, 105:2214-2219.
10. Puissant B., Barreau C., Bourin P., Clavel C., Corre J., Bousquet C., Taureau C., Cousin B., Abbal M., Laharrague P., Penicaud L., Casteilla L., Blancher A. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br. J. Haematol. 2005, 129:118-129.
11. Yanez R., Lamana M.L., Garcia-Castro J., Colmenero I., Ramirez M., Bueren J.A. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006, 24:2582-2591.
12. Sato K., Ozaki K., Oh I., Meguro A., Hatanaka K., Nagai T., Muroi K., Ozawa K. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007, 109:228-234.
13. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389-397.
14. Zhang W., Ge W., Li C., You S., Liao L., Han Q., Deng W., Zhao R.C. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev. 2004, 13:263-271.
15. Nauta A.J., Kruisselbrink A.B., Lurvink E., Willemze R., Fibbe W.E. Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J. Immunol. 2006, 177:2080-2087.
16. Gonzalez-Rey E., Gonzalez M.A., Varela N., O'Valle F., Hernandez-Cortes P., Rico L., Buscher D., Delgado M. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann. Rheum. Dis. 2010, 69:241-248.
17. in 't Anker P.S., Noort W.A., Kruisselbrink A.B., Scherjon S.A., Beekhuizen W., Willemze R., Kanhai H.H., Fibbe W.E. Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp. Hematol. 2003, 31:881-889.
18. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop D., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
19. Bieback K., Kern S., Kluter H., Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 2004, 22:625-634.
20. Kern S., Eichler H., Stoeve J., Kluter H., Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006, 24:1294-1301.
21. Baksh D., Yao R., Tuan R.S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007, 25:1384-1392.
22. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
23. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
24. Hwa C.H., Bae Y.C., Jung J.S. Role of toll-like receptors on human adipose-derived stromal cells. Stem Cells 2006, 24:2744-2752.
25. Liotta F., Angeli R., Cosmi L., Fili L., Manuelli C., Frosali F., Mazzinghi B., Maggi L., Pasini A., Lisi V., Santarlasci V., Consoloni L., Angelotti M.L., Romagnani P., Parronchi P., Krampera M., Maggi E., Romagnani S., Annunziato F. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signalling. Stem cells 2008, 26:279-289.
26. van den Berk L.C., Jansen B.J., Siebers-Vermeulen K.G., Netea M.G., Latuhihin T., Bergevoet S., Raymakers R.A., Kogler G., Figdor C.C., Adema G.J., Torensma R. Toll-like receptor triggering in cord blood mesenchymal stem cells. J. Cell Mol. Med. 2009, 13(9B):3415-3426.
27. Tomchuck S.L., Zwezdaryk K.J., Coffelt S.B., Waterman R.S., Danka E.S., Scandurro A.B. Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem cells 2008, 26:99-107.
28. Raicevic G., Rouas R., Najar M., Stordeur P., Boufker H.I., Bron D., Martiat P., Goldman M., Nevessignsky M.T., Lagneaux L. Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. Hum. Immunol. 2010, 71:235-244.
29. De Bruyn C., Najar M., Raicevic G., Meuleman N., Pieters K., Stamatopoulos B., Delforge A., Bron D., Lagneaux L. A rapid, simple and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells Dev. 2011, 20(3):547-557.
30. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., Benhaim P., Lorenz H.P., Hedrick M.H. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001, 7:211-228.
31. La Rocca G., Anzalone R., Corrao S., Magno F., Loria T., Lo I.M., Di Stefano A., Giannuzzi P., Marasa L., Cappello F., Zummo G., Farina F. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem. Cell Biol. 2009, 131:267-282.
32. Romieu-Mourez R., Francois M., Boivin M.N., Bouchentouf M., Spaner D.E., Galipeau J. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J. Immunol. 2009, 182:7963-7973.
33. St Onge M., Dumas A., Michaud A., Laflamme C., Dussault A.A., Pouliot M. Impact of anti-inflammatory agents on the gene expression profile of stimulated human neutrophils: unraveling endogenous resolution pathways. PLoS ONE 2009, 4:e4902.
34. Mailliard R.B., Wankowicz-Kalinska A., Cai Q., Wesa A., Hilkens C.M., Kapsenberg M.L., Kirkwood J.M., Storkus W.J., Kalinski P. Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res. 2004, 64:5934-5937.
35. Daxecker H., Raab M., Markovic S., Karimi A., Griesmacher A., Mueller M.M. Endothelial adhesion molecule expression in an in vitro model of inflammation. Clin. Chim. Acta. 2002, 325:171-175.
36. Umezawa A., Harigaya K., Abe H., Watanabe Y. Gap-junctional communication of bone marrow stromal cells is resistant to irradiation in vitro. Exp. Hematol. 1990, 18:1002-1007.
37. Bruhl P., Mergenthaler H.G., Dormer P. Haemopoietic inductive capacity of irradiated stromal cell layers in human micro long-term bone marrow cultures. Cell Tissue Kinet. 1988, 21:411-417.
38. Smythies L.E., Shen R., Bimczok D., Novak L., Clements R.H., Eckhoff D.E., Bouchard P., George M.D., Hu W.K., Dandekar S., Smith P.D. Inflammation anergy in human intestinal macrophages is due to Smad-induced IkappaBalpha expression and NF-kappaB inactivation. J. Biol. Chem. 2010, 285:19593-19604.
39. Sun J., Duffy K.E., Ranjith-Kumar C.T., Xiong J., Lamb R.J., Santos J., Masarapu H., Cunningham M., Holzenburg A., Sarisky R.T., Mbow M.L., Kao C. Structural and functional analyses of the human Toll-like receptor 3. Role of glycosylation. J. Biol. Chem. 2006, 281:11144-11151.
40. Ortiz L.A., Dutreil M., Fattman C., Pandey A.C., Torres G., Go K., Phinney D.G. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc. Natl. Acad. Sci. USA 2007, 104:11002-11007.
41. Ren G., Zhang L., Zhao X., Xu G., Zhang Y., Roberts A.I., Zhao R.C., Shi Y. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2008, 2:141-150.
42. Appay V., Dunbar P.R., Cerundolo V., McMichael A., Czaplewski L., Rowland-Jones S. RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation. Int. Immunol. 2000, 12:1173-1182.
43. Appay V., Rowland-Jones S.L. RANTES: a versatile and controversial chemokine. Trends Immunol. 2001, 22:83-87.
44. DelaRosa O., Lombardo E. Modulation of adult mesenchymal stem cells activity by toll-like receptors: implications on therapeutic potential. Mediators Inflamm. 2010, 2010:865601.
45. Harada A., Sekido N., Akahoshi T., Wada T., Mukaida N., Matsushima K. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukoc. Biol. 1994, 56:559-564.
46. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., Elner S.G., Strieter R.M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801.
47. Prasanna S.J., Gopalakrishnan D., Shankar S.R., Vasandan A.B. Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS ONE 2010, 5(2):e9016.
48. Crop M.J., Baan C.C., Korevaar S.S., Ijzermans J.N., Pescatori M., Stubbs A.P., Van Ijcken W.F., Dahlke M.H., Eggenhofer E., Weimar W., Hoogduijn M.J. Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clin. Exp. Immunol. 2010, 162(3):474-486.
49. Hemeda H., Jakob M., Ludwig A.K., Giebel B., Lang S., Brandau S. Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells. Stem Cells Dev. 2010, 19:693-706.
50. Takeda A., Hamano S., Yamanaka A., Hanada T., Ishibashi T., Mak T.W., Yoshimura A., Yoshida H. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 2003, 170:4886-4890.
51. Yoshimura T., Takeda A., Hamano S., Miyazaki Y., Kinjyo I., Ishibashi T., Yoshimura A., Yoshida H. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J. Immunol. 2006, 177:5377-5385.
52. Opitz C.A., Litzenburger U.M., Lutz C., Lanz T.V., Tritschler I., Koppel A., Tolosa E., Hoberg M., Anderl J., Aicher W.K., Weller M., Wick W., Platten M. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2, 3-dioxygenase-1 via interferon-beta and protein kinase R. Stem cells 2009, 27:909-919.
53. Lombardo E., DelaRosa O., Mancheno-Corvo P., Menta R., Ramirez C., Buscher D. Toll-like receptor-mediated signaling in human adipose-derived stem cells: implications for immunogenicity and immunosuppressive potential. Tissue Eng. Part A 2009, 15:1579-1589.
54. Yoo K.H., Jang I.K., Lee M.W., Kim H.E., Yang M.S., Eom Y., Lee J.E., Kim Y.J., Yang S.K., Jung H.L., Sung K.W., Kim C.W., Koo H.H. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. Cell Immunol. 2009, 259:150-156.
55. Najar M., Raicevic G., Boufker H.I., Fayyad K.H., De Bruyn C., Meuleman N., Bron D., Toungouz M., Lagneaux L. Mesenchymal stromal cells use PGE2 to modulate activation and proliferation of lymphocyte subsets: Combined comparison of adipose tissue, Wharton's Jelly and bone marrow sources. Cell Immunol. 2010, 264:171-179.
56. Wang Y., Abarbanell A.M., Herrman J.L., Weil B.R., Manukyan M.C., Poynter J.A., Meldrum D.R. TLR4 inhibits mesenchymal stem cells (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection. PLoS ONE 2010, 5:e14206.
57. Nasef A., Mazurier C., Bouchet S., Francois S., Chapel A., Thierry D., Gorin N.C., Fouillard L. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. Cell Immunol. 2008, 253:16-22.
58. Greschat S., Schira J., Kury P., Rosenbaum C., Souza Silva M.A., Kogler G., Wernet P., Muller H.W. Unrestricted somatic stem cells from human umbilical cord blood can be differentiated into neurons with a dopaminergic phenotype. Stem Cells Dev. 2008, 17:221-232.
59. Foldes G., Liu A., Badiger R., Paul-Clark M., Moreno L., Lendvai Z., Wright J.S., Ali N.N., Harding S.E., Mitchell J.A. Innate immunity in human embryonic stem cells: comparison with adult human endothelial cells. PLoS ONE 2010, 5:e10501.
60. Zampetaki A., Xiao Q., Zeng L., Hu Y., Xu Q. TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modifications. Biochem. Biophys. Res.Commun. 2006, 347:89-99.